Similar articles

• Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.

  Korraa H, Saadeh C. Korraa H, et al. South Med J. 1996 Mar;89(3):272-7. doi: 10.1097/00007611-199603000-00003. South Med J. 1996. PMID: 8604455 Review.
• [Therapy and prevention of pneumocystis carinii pneumonia].

  Goebel FD, Bogner JR. Goebel FD, et al. Internist (Berl). 1995 Dec;36(12):1150-5. Internist (Berl). 1995. PMID: 8567220 Review. German. No abstract available.
• Current management practices in the treatment of Pneumocystis carinii pneumonia (PCP).

  Blanchet KD. Blanchet KD. AIDS Patient Care STDS. 1996 Apr;10(2):116-21. doi: 10.1089/apc.1996.10.116. AIDS Patient Care STDS. 1996. PMID: 11361688 No abstract available.
• Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia.

  Lee WS, Hsueh PR, Hsieh TC, Chen FL, Ou TY, Jean SS. Lee WS, et al. J Microbiol Immunol Infect. 2017 Aug;50(4):547-548. doi: 10.1016/j.jmii.2016.03.008. Epub 2016 Mar 28. J Microbiol Immunol Infect. 2017. PMID: 27094385 No abstract available.
• Treatment of Pneumocystis carinii pneumonia in adults with AIDS.

  Deresinski SC. Deresinski SC. Semin Respir Infect. 1997 Jun;12(2):79-97. Semin Respir Infect. 1997. PMID: 9195673 Review.